4//SEC Filing
LASEZKAY GEORGE M 4
Accession 0001209191-20-051898
CIK 0001539029other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 4:42 PM ET
Size
5.7 KB
Accession
0001209191-20-051898
Insider Transaction Report
Form 4
LASEZKAY GEORGE M
DirectorCEO
Transactions
- Sale
Common Stock
2020-09-22$1.59/sh−13,411$21,323→ 302,689 total
Footnotes (3)
- [F1]The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.56 to $1.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes 5,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2020.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001020514
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 4:42 PM ET
- Size
- 5.7 KB